| 000 | 01859naaaa2200313uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/55791 | ||
| 005 | 20220220052108.0 | ||
| 020 | _a9783038429432 | ||
| 020 | _a9783038429449 | ||
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aEvanthia Bernitsas (Ed.) _4auth |
|
| 245 | 1 | 0 | _aPathophysiology and Imaging Diagnosis of Demyelinating Disorders |
| 260 |
_bMDPI - Multidisciplinary Digital Publishing Institute _c2018 |
||
| 300 | _a1 electronic resource (X, 168 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aDemyelinating disorders are chronic autoimmune disorders characterized by inflammation, demyelination, axonal degeneration, and neuronal loss. They have complex pathophysiology and diverse clinical presentations. The etiology of these disorders lies in the interaction between genetic and environmental factors. Due to the complexity in pathophysiology and presentation, diagnosis and treatment can be challenging. Advanced technology, including modern imaging techniques, as well as optical coherence tomography (OCT), enrich our understanding of the disease process, improve diagnostic accuracy, and may guide treatment decisions. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by-nc-nd/4.0/ _2cc _4https://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aEnglish | ||
| 653 | _ademyelinating disorders | ||
| 653 | _atherapeutics | ||
| 653 | _aautoimmune | ||
| 653 | _aoptical coherence tomography | ||
| 653 | _amultiple sclerosis | ||
| 653 | _aneuroimaging | ||
| 653 | _aremyelination | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttp://www.mdpi.com/books/pdfview/book/659 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/55791 _70 _zDOAB: description of the publication |
| 999 |
_c67552 _d67552 |
||